Scientists Team Up With AI To Develop Treatment For Childhood Brain Cancer

Scientists in the UK have used artificial intelligence (AI) to devise a treatment for children suffering from a rare form of brain cancer.

Computer scientists and cancer specialists in the UK have used artificial intelligence (AI) to devise an effective treatment for children suffering from a “rare and aggressive” form of brain cancer. Artificial intelligence is widely used for a variety of applications, including cybersecurity, machine translation, agriculture, manufacturing, combating online disinformation, improving rail and air traffic safety and efficiency, and more.

AI is also widely used in healthcare to crack data and discover patterns that can help diagnose diseases and lead to the discovery of new medical therapies. While the positive aspects of AI are becoming clearer by the day, public opinion on the technology remains divided, with most people wanting strict regulations to ensure that algorithms are not used in a way that could harm the privacy and freedom of people. people .

Related: This Affectionate Virtual Partner Is The Most Popular AI In The World

The new research on brain cancer in children comes from scientists, doctors and data analysts at The Institute of Cancer Research (ICR) in London, and the results are published in the journal Cancer Discovery. According to the report, researchers from the ICR and the Royal Marsden NHS Foundation Trust used AI to devise a treatment regimen to treat children suffering from a rare and deadly form of brain cancer called Diffuse Intrinsic Pontine Glioma (DIPG). The report further states that the two drugs being tested for treatment are Everolimus and Vandetanib, which could be used together to improve patient survival.

AI-powered treatment extended survival in mice by 14%

Initial tests have shown that the AI-powered treatment has improved survival rates in mice by 14% and is currently being tested in children. In the future, the researchers hope to launch much larger clinical trials involving many more children. Researchers call the discovery “exciting” and say it has the potential to become “one of the first examples of an AI-proposed treatment that benefits patients.” According to them, survival rates for the deadly disease have not improved in the past 50 years, but the new AI-powered therapy has the potential to change that for the better.

DIPG remains a fatal disease because surgical removal of the tumors is often extremely difficult. However, the AI ​​algorithm processed the available data on the two aforementioned drugs and found that Everolimus could improve the effectiveness of Vandetanib by helping it “sneak past the blood-brain barrier,” said Chris Jones, professor of childhood brain tumor biology at the ICR. It remains to be seen how the larger clinical trials progress, but if successful, the new therapy could cause a paradigm shift in the treatment of children suffering from DIPG.

Next: AI algorithm identifies age and ethnicity, but researchers don’t know how it works

Source: The Guardian

Venom: Let There Be Carnage Official Runtime Confirmed

Comments are closed.